
Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE)
A blend of e-learning, case studies, assessments, interactive pdfs and posters.
Look and feel

The training need
The Medicines and Healthcare Products Regulatory Agency (MHRA) sought a supplier to create a suite of digital assets supporting the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) project.
The Safety and Vigilance (SAV) unit enhances global medical product safety by coordinating international networks for information sharing through databases, monitoring, and alert systems. It also helps countries build national capacities for post-marketing surveillance. The Joint Action ensures consistent pharmacovigilance operations across the EU, strengthening medicine safety and communication to protect public health.
The SCOPE project gathered information and expertise on how regulators in Member States manage national pharmacovigilance systems and identified the need for tools and resources to support best practices.

Specific requirements of the e-learning included:
- Develop a variety of tools and resources to support and embed best practices.
Our bespoke learning solution
Aware that the target audience comprised of graduate and postgraduate HCPs working within pharmacovigilance teams, Aleido ensured that the work was organised into six work packages including:
- WP1 – Coordination
- WP2 – Dissemination
- WP3 – Evaluation
- WP4 – ADR Collection
- WP5 – Signal Management
- WP6 – Risk Communications
- WP7 – Quality Management Systems
- WP8 – Livecycle Pharmacovigilance
Packages each comprised an appropriate blend of e-learning, case studies, assessments, interactive pdfs, animations, GIFs, posters etc to meet each work package’s particular focus. The project was spread across 28 member states, requiring inter-agency communications with dozens of Work Package leads and subject matter experts. The e-learning used character audio to represent real life scenarios based around a telephone reporting system for adverse drug reactions.
features
- E-learning
- Mobile friendly, non-responsive
- Marketing collateral
- Consultancy/ research
- Blended
- Video
- Animation
- Simulation
CAse studies
Contact
Interested in our services? We'd love to hear from you...
.jpg)
Andy Wiles
Department Manager
Aleido Learning UK
+44 (0) 1926 642935
- at https://form.apsis.one/fR8OUeUdJYWRKv